Sphingosylphosphorylcholine inhibits plasma cell differentiation and ameliorates experimental autoimmune encephalomyelitis.

MLA

Byunghyun Park, et al. “Sphingosylphosphorylcholine Inhibits Plasma Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.” Frontiers in Immunology, July 2023, pp. 1–11. EBSCOhost, https://doi.org/10.3389/fimmu.2023.1151511.

APA

Byunghyun Park, Yu Sun Jeong, Wonseok Hu, Mingyu Lee, Ji Cheol Kim, Geon Ho Bae, Yong-Soo Bae, & Yoe-Sik Bae. (2023). Sphingosylphosphorylcholine inhibits plasma cell differentiation and ameliorates experimental autoimmune encephalomyelitis. Frontiers in Immunology, 1–11. https://doi.org/10.3389/fimmu.2023.1151511

Chicago

Byunghyun Park, Yu Sun Jeong, Wonseok Hu, Mingyu Lee, Ji Cheol Kim, Geon Ho Bae, Yong-Soo Bae, and Yoe-Sik Bae. 2023. “Sphingosylphosphorylcholine Inhibits Plasma Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.” Frontiers in Immunology, July, 1–11. doi:10.3389/fimmu.2023.1151511.